http://www.sciencedirect.com/science/article/pii/S0006899312015806
Abstract
The
beneficial effects of simvastatin on experimental traumatic brain
injury (TBI) have been demonstrated in previous studies. In this study,
we investigated the effects of simvastatin on axonal injury and neurite
outgrowth after experimental TBI and explored the underlying mechanisms.
Wistar rats were subjected to controlled cortical impact or sham
surgery. Saline or simvastatin was administered for 14 days. A modified
neurological severity score (mNSS) test was performed to evaluate
functional recovery. Immunohistochemistry studies using synaptophysin,
neurofilament H (NF-H) and amyloid-β precursor protein (APP)
were performed to examine synaptogenesis and axonal injury. Primary
cortical neurons (PCNs) were subjected to oxygen glucose deprivation
(OGD) followed by various treatments. Western blot analysis was utilized
to assess the activation of phosphatidylinositol-3 kinase
(PI-3 K)/Akt/mammalian target of rapamycin (mTOR) and glycogen synthase
kinase 3β (GSK-3β)/adenomatous polyposis coli (APC)
pathways. Simvastatin decreased the density of APP-positive profiles and
increased the density of NF-H -positive profiles. Simvastatin reduced
mNSS, which was correlated with the increase of axonal density.
Simvastatin treatment stimulated the neurite outgrowth of PCNs after
OGD, which was attenuated by LY294002 and enhanced by lithium chloride
(LiCl). Simvastatin activated Akt and mTOR, inactivated GSK-3β
and dephosphorylated APC in the injured PCNs. Our data suggest that
simvastatin reduces axonal injury, enhances neurite outgrowth and
promotes neurological functional recovery after experimental TBI. The
beneficial effects of simvastatin on neurite outgrowth may be mediated
through manipulation of the PI-3 K/Akt/mTOR and PI-3 K/GSK-3β/APC pathways.
Ha simvastatin wonder drug or not?
ReplyDelete